ROMVYNZA
Live / Applied — Third extension granted (statement of use) (as of 13 Jan 2026)
What this means for you
Not registered yet, but its 25 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98238959
- Mark type
- Stylized text
- Filed
- 25 Oct 2023
- Published for opposition
- 28 May 2024
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD) and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
Owner
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
Prosecution history
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2026 — SOU EXTENSION 3 GRANTED
- 13 Jan 2026 — SOU EXTENSION 3 FILED
- 13 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2025 — SOU EXTENSION 2 GRANTED
- 15 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2025 — SOU EXTENSION 1 GRANTED
- 08 Jan 2025 — SOU EXTENSION 1 FILED
- 08 Jan 2025 — SOU TEAS EXTENSION RECEIVED